Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Gardasil®
Condition(s):Dengue Fever; Dengue Hemorrhagic Fever; Human Papillomavirus DiseaseLast Updated:March 25, 2022Completed
Hide Studies Not Open or Pending
Condition(s):Dengue Fever; Dengue Hemorrhagic Fever; Human Papillomavirus DiseaseLast Updated:March 25, 2022Completed
Condition(s):Chronic Kidney DiseaseLast Updated:July 24, 2017Completed
Condition(s):HPV-Related CarcinomaLast Updated:June 10, 2021Unknown status
Condition(s):Vaccine Administration RatesLast Updated:March 7, 2018Withdrawn
Condition(s):Papillomavirus InfectionsLast Updated:May 31, 2023Completed
Condition(s):Human; Papillomavirus InfectionsLast Updated:February 20, 2018Completed
Condition(s):Cervical CancerLast Updated:October 1, 2021Completed
Condition(s):Cervical CancerLast Updated:October 12, 2015Completed
Condition(s):HPV InfectionsLast Updated:October 9, 2015Completed
Condition(s):Dose Schedule StudyLast Updated:April 14, 2017Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.